Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Journey Medical (DERM) Operating Margin (2020 - 2025)

Historic Operating Margin for Journey Medical (DERM) over the last 6 years, with Q3 2025 value amounting to 8.67%.

  • Journey Medical's Operating Margin rose 111100.0% to 8.67% in Q3 2025 from the same period last year, while for Sep 2025 it was 9.25%, marking a year-over-year increase of 219300.0%. This contributed to the annual value of 24.36% for FY2024, which is 217500.0% down from last year.
  • As of Q3 2025, Journey Medical's Operating Margin stood at 8.67%, which was up 111100.0% from 19.16% recorded in Q2 2025.
  • Journey Medical's 5-year Operating Margin high stood at 49.93% for Q3 2023, and its period low was 90.02% during Q2 2021.
  • For the 5-year period, Journey Medical's Operating Margin averaged around 31.87%, with its median value being 25.3% (2025).
  • Its Operating Margin has fluctuated over the past 5 years, first plummeted by -781300bps in 2021, then soared by 1088300bps in 2023.
  • Quarter analysis of 5 years shows Journey Medical's Operating Margin stood at 51.7% in 2021, then fell by -21bps to 62.6% in 2022, then surged by 78bps to 13.79% in 2023, then soared by 219bps to 16.4% in 2024, then plummeted by -153bps to 8.67% in 2025.
  • Its Operating Margin was 8.67% in Q3 2025, compared to 19.16% in Q2 2025 and 25.3% in Q1 2025.